Related Experiment Video
Updated: Jun 12, 2026

Transport Properties of Ibuprofen Encapsulated in Cyclodextrin Nanosponge Hydrogels: A Proton HR-MAS NMR Spectroscopy Study
Published on: August 15, 2016
Oral modified-release formulations in motion: the relationship between gastrointestinal transit and drug absorption
Felipe J O Varum1, Hamid A Merchant, Abdul W Basit
1The School of Pharmacy, University of London, 29/39 Brunswick Square, London WC1N 1AX, United Kingdom.
Abstract:
Oral modified-release dosage forms can be designed with the aim of achieving specific pharmacokinetic profiles, delivering to specific gut localities or reducing the number of drug administrations. Multiple-unit systems, such as pellets, beads or granules, often claim superiority to single-unit modified-release formulations in terms of predictability and reproducibility of behaviour in the gastrointestinal tract. This is an oversimplification and in this review we discuss the effect of the highly variable gastrointestinal transit on the bioperformance of multiple-unit dosage forms, relative to their single-unit counterparts. We examine the sometimes contradictory literature in this area and highlight specific case studies which demonstrate the effect of intestinal transit on dosage form performance and drug absorption.
Related Concept Videos
Modified-Release Drug Delivery Systems: Bioavailability
Oral Drug Delivery Systems: Continuous-Release Systems
Modified-Release Drug Delivery Systems: Overview
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Factors Influencing Drug Absorption: Anatomical Parameters
Factors Influencing Drug Absorption: Drug Dissolution

